232 related articles for article (PubMed ID: 23255198)
1. Nanosuspension based in situ gelling nasal spray of carvedilol: development, in vitro and in vivo characterization.
Saindane NS; Pagar KP; Vavia PR
AAPS PharmSciTech; 2013 Mar; 14(1):189-99. PubMed ID: 23255198
[TBL] [Abstract][Full Text] [Related]
2. Development, Optimization, and Evaluation of Carvedilol-Loaded Solid Lipid Nanoparticles for Intranasal Drug Delivery.
Aboud HM; El Komy MH; Ali AA; El Menshawe SF; Abd Elbary A
AAPS PharmSciTech; 2016 Dec; 17(6):1353-1365. PubMed ID: 26743643
[TBL] [Abstract][Full Text] [Related]
3. Mucoadhesive chitosan microspheres of carvedilol for nasal administration.
Patil S; Babbar A; Mathur R; Mishra A; Sawant K
J Drug Target; 2010 May; 18(4):321-31. PubMed ID: 20199172
[TBL] [Abstract][Full Text] [Related]
4. Formulation and evaluation of mucoadhesive buccal films impregnated with carvedilol nanosuspension: a potential approach for delivery of drugs having high first-pass metabolism.
Rana P; Murthy RS
Drug Deliv; 2013; 20(5):224-35. PubMed ID: 23651066
[TBL] [Abstract][Full Text] [Related]
5. Nanotransfersomes of carvedilol for intranasal delivery: formulation, characterization and in vivo evaluation.
Aboud HM; Ali AA; El-Menshawe SF; Elbary AA
Drug Deliv; 2016 Sep; 23(7):2471-2481. PubMed ID: 25715807
[TBL] [Abstract][Full Text] [Related]
6. Controlled delivery of carvedilol nanosuspension from osmotic pump capsule: in vitro and in vivo evaluation.
Liu D; Yu S; Zhu Z; Lyu C; Bai C; Ge H; Yang X; Pan W
Int J Pharm; 2014 Nov; 475(1-2):496-503. PubMed ID: 25219321
[TBL] [Abstract][Full Text] [Related]
7. Fabrication of an ionic-sensitive in situ gel loaded with resveratrol nanosuspensions intended for direct nose-to-brain delivery.
Hao J; Zhao J; Zhang S; Tong T; Zhuang Q; Jin K; Chen W; Tang H
Colloids Surf B Biointerfaces; 2016 Nov; 147():376-386. PubMed ID: 27566226
[TBL] [Abstract][Full Text] [Related]
8. Preparation, optimization, and in vitro simulated inhalation delivery of carvedilol nanoparticles loaded on a coarse carrier intended for pulmonary administration.
Abdelbary AA; Al-mahallawi AM; Abdelrahim ME; Ali AM
Int J Nanomedicine; 2015; 10():6339-53. PubMed ID: 26491298
[TBL] [Abstract][Full Text] [Related]
9. Nose-to-Brain Delivery by Nanosuspensions-Based in situ Gel for Breviscapine.
Chen Y; Liu Y; Xie J; Zheng Q; Yue P; Chen L; Hu P; Yang M
Int J Nanomedicine; 2020; 15():10435-10451. PubMed ID: 33380794
[TBL] [Abstract][Full Text] [Related]
10. Nasal delivery of nanosuspension-based mucoadhesive formulation with improved bioavailability of loratadine: Preparation, characterization, and in vivo evaluation.
Alshweiat A; Csóka I; Tömösi F; Janáky T; Kovács A; Gáspár R; Sztojkov-Ivanov A; Ducza E; Márki Á; Szabó-Révész P; Ambrus R
Int J Pharm; 2020 Apr; 579():119166. PubMed ID: 32084574
[TBL] [Abstract][Full Text] [Related]
11. Development and evaluation of carvedilol-loaded transdermal drug delivery system: In-vitro and in-vivo characterization study.
Kshirsagar SJ; Bhalekar MR; Mohapatra SK
Drug Dev Ind Pharm; 2012 Dec; 38(12):1530-7. PubMed ID: 22356303
[TBL] [Abstract][Full Text] [Related]
12. Development of Carvedilol Nanoformulation-Loaded Poloxamer-Based In Situ Gel for the Management of Glaucoma.
Almutairy BK; Khafagy ES; Abu Lila AS
Gels; 2023 Dec; 9(12):. PubMed ID: 38131938
[TBL] [Abstract][Full Text] [Related]
13. Design and evaluation of polymer coated carvedilol loaded solid lipid nanoparticles to improve the oral bioavailability: a novel strategy to avoid intraduodenal administration.
Venishetty VK; Chede R; Komuravelli R; Adepu L; Sistla R; Diwan PV
Colloids Surf B Biointerfaces; 2012 Jun; 95():1-9. PubMed ID: 22463845
[TBL] [Abstract][Full Text] [Related]
14. In vivo evaluation of alginate microspheres of carvedilol for nasal delivery.
Patil SB; Kaul A; Babbar A; Mathur R; Mishra A; Sawant KK
J Biomed Mater Res B Appl Biomater; 2012 Jan; 100(1):249-55. PubMed ID: 22113887
[TBL] [Abstract][Full Text] [Related]
15. Carboxylated mesoporous carbon microparticles as new approach to improve the oral bioavailability of poorly water-soluble carvedilol.
Zhang Y; Zhi Z; Li X; Gao J; Song Y
Int J Pharm; 2013 Sep; 454(1):403-11. PubMed ID: 23850816
[TBL] [Abstract][Full Text] [Related]
16. Mucoadhesive bilayer buccal tablet of carvedilol-loaded chitosan microspheres: in vitro, pharmacokinetic and pharmacodynamic investigations.
Yedurkar P; Dhiman MK; Petkar K; Sawant K
J Microencapsul; 2012; 29(2):126-37. PubMed ID: 22047549
[TBL] [Abstract][Full Text] [Related]
17. Comparative study on stabilizing ability of food protein, non-ionic surfactant and anionic surfactant on BCS type II drug carvedilol loaded nanosuspension: Physicochemical and pharmacokinetic investigation.
Geng T; Banerjee P; Lu Z; Zoghbi A; Li T; Wang B
Eur J Pharm Sci; 2017 Nov; 109():200-208. PubMed ID: 28811130
[TBL] [Abstract][Full Text] [Related]
18. Novel chitosan-functionalized spherical nanosilica matrix as an oral sustained drug delivery system for poorly water-soluble drug carvedilol.
Sun L; Wang Y; Jiang T; Zheng X; Zhang J; Sun J; Sun C; Wang S
ACS Appl Mater Interfaces; 2013 Jan; 5(1):103-13. PubMed ID: 23237208
[TBL] [Abstract][Full Text] [Related]
19. Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties.
Zaki NM; Awad GA; Mortada ND; Abd Elhady SS
Eur J Pharm Sci; 2007 Dec; 32(4-5):296-307. PubMed ID: 17920822
[TBL] [Abstract][Full Text] [Related]
20. Preparation of Tamsulosin Hydrochloride-Loaded Mucoadhesive In Situ Gelling Polymeric Formulation for Nasal Delivery in Geriatrics.
Rana SJ; Zafar S; Shahzad A; Basit M; Mudassir J; Akhlaq M; Chohan TA; Arshad MS
AAPS PharmSciTech; 2023 Nov; 24(8):242. PubMed ID: 38017208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
